Similar articles

• A tale of two tumors: pediatric and adult medulloblastoma.

  Aizer AA, Chan AW. Aizer AA, et al. Oncology (Williston Park). 2012 Nov;26(11):1095-7. Oncology (Williston Park). 2012. PMID: 23330354 No abstract available.
• Adult medulloblastoma, from spongioblastoma cerebelli to the present day: a review of treatment and the integration of molecular markers.

  Shonka N, Brandes A, De Groot JF. Shonka N, et al. Oncology (Williston Park). 2012 Nov;26(11):1083-91. Oncology (Williston Park). 2012. PMID: 23330353 Review.
• Perspectives in the management of central nervous system tumours.

  Ansari BM. Ansari BM. Indian J Pediatr. 1993 Mar-Apr;60(2):237-43. doi: 10.1007/BF02822182. Indian J Pediatr. 1993. PMID: 8244498 Review.
• High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.

  Pérez-Martínez A, Lassaletta A, González-Vicent M, Sevilla J, Díaz MA, Madero L. Pérez-Martínez A, et al. J Neurooncol. 2005 Jan;71(1):33-8. doi: 10.1007/s11060-004-4527-4. J Neurooncol. 2005. PMID: 15719272 Clinical Trial.
• High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.

  Sung KW, Yoo KH, Cho EJ, Koo HH, Lim DH, Shin HJ, Ahn SD, Ra YS, Choi ES, Ghim TT. Sung KW, et al. Pediatr Blood Cancer. 2007 Apr;48(4):408-15. doi: 10.1002/pbc.21064. Pediatr Blood Cancer. 2007. PMID: 17066462 Clinical Trial.